Home | GSK AU
WEBOur strategy. We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.
Company | GSK AU
WEBGSK at a glance. Getting ahead means preventing disease as well as treating it. Globally, our portfolio spans vaccines, specialty and general medicines, with R&D focused on science of the immune system, human genetics and advanced technologies. £5.3 billion ($AUD 9.4 billion) R&D investment in 2021.
Contact Us - GSK
WEBWe are a global biopharma company. With ambition and purpose to unite science, technology and talent to get ahead of disease. Contact Details. GSK Australia. Level 4, 436 Johnston Street, Abbotsford, Victoria, 3067. PO Box 18095, Melbourne, Victoria, 8003. Telephone: 1800 033 109 or +61 3 9413 7200. Fax: +61 3 8761 2442.
COVID-19 treatment: GlaxoSmithKline Australia Pty Ltd, …
WEBSep 23, 2022 · On 20 August 2021, the Therapeutic Goods Administration (TGA), part of the Department of Health, granted provisional approval to GlaxoSmithKline (GSK) Australia Pty Ltd for its COVID-19 treatment-sotrovimab (XEVUDY)-making it the second COVID-19 treatment to receive regulatory approval in Australia. Australia is the …
TGA provisionally approves GlaxoSmithKline's COVID-19 …
WEBOn 20 August 2021, the Therapeutic Goods Administration (TGA), part of the Department of Health, granted provisional approval to GlaxoSmithKline (GSK) Australia Pty Ltd for its COVID-19 treatment - sotrovimab (XEVUDY) - making it the second COVID-19 treatment to receive regulatory approval in Australia. Australia is the first OECD country to ...
TGA grants provisional determination to Glaxo SmithKline Australia Pty ...
WEBThe Therapeutic Goods Administration (TGA), part of the Department of Health, has granted a provisional determination to GlaxoSmithKline Australia Pty Ltd (GSK) in relation to the monoclonal antibody treatment, SOTROVIMAB (GSK4182136).
Valuable and timely information for healthcare professionals
WEBA portal for Australian healthcare professionals which provides timely, relevant information on GSK products, related therapy areas, events and webinars.
GLAXOSMITHKLINE AUSTRALIA PTY LTD - Dun & Bradstreet
WEBFind company research, competitor information, contact details & financial data for GLAXOSMITHKLINE AUSTRALIA PTY LTD of ABBOTSFORD, VICTORIA. Get the latest business insights from Dun & Bradstreet.
Haleon to invest more in Australia after split from GlaxoSmithKline
WEBJul 19, 2022 – 4.56pm. Haleon, the maker of Sensodyne toothpaste and Advil painkillers, will invest more in Australia – including in a data and technology centre and a new head office – as a...
At a glance | GSK AU
WEBGSK is now a fully focussed biopharma company with a new purpose: to unite science, technology and talent to get ahead of disease together. We aim to impact the health of 2.5 billion people over the next 10 years.
Skip to content